Skip to main content

Steven Daniel

Cofactor Genomics has appointed Steven Daniel as VP of business development. Daniel previously served as senior director of applied sciences and business development at ArcherDx. Prior to ArcherDx, he was VP of sales at Genos/Nantomics, senior director of pharma business development at Adaptive Biotechnologies, and held commercial roles at Life Technologies, AltheaDX, Metabolon, and Affymetrix.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.